Jianglei Huang

Title: Jianglei Huang: Innovator in Pharmaceutical Chemistry

Introduction

Jianglei Huang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that target critical pathways in cancer treatment.

Latest Patents

Huang holds a patent for "Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors." This patent discloses a novel class of MDM2-p53 inhibitor compounds featuring an imidaxopyrolone structure. Specifically, the patent details compounds represented by formulas (I-1) and (I-2), along with their pharmaceutically acceptable salts. This innovation has the potential to advance therapeutic options for cancer patients.

Career Highlights

Throughout his career, Jianglei Huang has worked with prominent companies in the pharmaceutical industry. He has been associated with Luoxin Pharmaceutical (Shanghai) Co., Ltd. and Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. His work in these organizations has contributed to the development of innovative pharmaceutical solutions.

Collaborations

Huang has collaborated with esteemed colleagues, including Kevin X Chen and Xiaobing Yan. These partnerships have fostered a collaborative environment that enhances research and development efforts in the pharmaceutical sector.

Conclusion

Jianglei Huang is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new cancer therapies. His innovative patents and collaborations highlight his commitment to advancing medical science.